Form 4: Vireo Growth Inc. Co-Executive Chairman Receives 7 Million Restricted Stock Units

Vireo Growth Inc.'s Co-Executive Chairman, Kyle E. Kingsley, was granted 7 million restricted stock units, vesting over the next two years.

Summary

• Dr. Kyle E. Kingsley, Co-Executive Chairman of Vireo Growth Inc., was granted 7,000,000 subordinate voting shares in the form of restricted stock units (RSUs).
• The RSUs were granted under the company's 2019 Equity Incentive Plan.
• 3,500,000 of the RSUs will vest on December 17, 2025.
• The remaining 3,500,000 RSUs will vest in equal installments of 875,000 on March 17, 2026, June 17, 2026, September 17, 2026, and December 17, 2026.
• Vesting is contingent on Dr. Kingsley remaining a service provider on each vesting date.
• Vesting may also occur upon a change in control of the parent company or the employer, or upon Dr. Kingsley's separation from service.

Sentiment

Score: 7

Explanation: The document is a routine filing related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns executive interests with the company's performance.

Positives

• The grant of RSUs aligns Dr. Kingsley's interests with the long-term success of the company.
• The vesting schedule encourages continued service and commitment from Dr. Kingsley.

Risks

• The vesting of the RSUs is contingent on Dr. Kingsley's continued service, which could be a risk if he were to leave the company before the vesting dates.
• The potential for accelerated vesting upon a change of control could lead to dilution of existing shareholders.

Future Outlook

The document outlines the vesting schedule for the granted RSUs, indicating the future equity ownership of Dr. Kingsley.

Industry Context

The granting of RSUs is a common practice in the industry to incentivize and retain key executives.

Comparison to Industry Standards

• The use of restricted stock units as part of executive compensation is a standard practice in publicly traded companies.
• Vesting schedules are typically structured to align executive interests with long-term company performance, similar to other companies in the cannabis industry such as Curaleaf and Trulieve.

Stakeholder Impact

• Shareholders may experience dilution upon the vesting of the RSUs.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Next Steps

• The company will continue to monitor the vesting schedule of the RSUs.
• Dr. Kingsley will need to remain a service provider to receive the vested shares.

Key Dates

Keywords

restricted stock units, RSUs, equity incentive plan, vesting, executive compensation, Vireo Growth Inc., Kyle E. Kingsley